文献速递血栓与止血

评估未来妊娠期及产后血栓预防研究价值的信息价值分析

Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis.
PubMed 文献 · J Thromb Haemost · 2024-01-11

该研究建立决策分析模型,模拟不同血栓预防策略的临床结局、终身成本与质量调整生命年,并用完美信息期望值和样本信息期望值分析评估未来研究价值。每组300名参与者)。

要点

  • 既往VTE妇女的试验价值更高但可接受性较低,未来研究应聚焦于无既往VTE的肥胖产后妇女。

核心结论

  • 未来研究应聚焦于估计无既往VTE且具有额外危险因素的肥胖产后妇女中血栓预防的有效性。

研究设计与样本

  • 开发决策分析模型,模拟不同血栓预防策略的临床结局、终身成本和健康与社会服务视角下的质量调整生命年。
  • 策略包括全部血栓预防、无血栓预防和基于风险评模型的血管预防。
  • 使用完美信息期望值分析确定与高决策不确定性相关的因素,并使用样本信息期望值分析估计未来研究的价值。

主要发现

  • 决策不确定性主要归因于血栓预防降低VTE有效性的不确定性。
  • 在既往VTE妇女中开展试验的价值更高但可接受性较低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk assessment models (RAMs) are used to select women at increased risk of venous thromboembolism (VTE) during pregnancy and the puerperium for thromboprophylaxis. OBJECTIVES: To estimate the value of potential future studies that would reduce the decision uncertainty associated with offering thromboprophylaxis according to available RAMs in the following groups: high-risk antepartum women (eg, prior VTE), unselected postpartum women, and postpartum women with risk factors (obesity or cesarean delivery). METHODS: A decision-analytic model was developed to simulate clinical outcomes, lifetime costs, and quality-adjusted life-years for different thromboprophylaxis strategies, including thromboprophylaxis for all, thromboprophylaxis for none, and RAM-based thromboprophylaxis. The expected value of perfect information analysis was used to determine which factors are associated with high decision uncertainty. The value of future research studies was estimated using expected value of sample information analysis. Costs were assessed from a health and social services perspective. RESULTS: The expected value of perfect information analysis identified high decision uncertainty for high-risk antepartum women (£21.8 million) and obese postpartum women (£13.4 million), which was largely attributable to uncertainty regarding the effectiveness of thromboprophylaxis in reducing VTE. A randomized controlled trial of thromboprophylaxis compared with none in obese postpartum women is likely to have substantial value (£2.8 million; 300 participants per arm). A trial in women with previous VTE would have higher value but would be less acceptable. CONCLUSION: Future research should focus on estimating the effectiveness of thromboprophylaxis in obese postpartum women with additional risk factors who have not had a previous VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Davis S, Pandor A, Sampson FC, et al. Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis. J Thromb Haemost. 2024. PMID: 38215911. doi:10.1016/j.jtha.2023.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。